JUNE Medical has announced a new agreement with a US hospital group to supply the award-winning Galaxy II self-retaining surgical retractors to over 1,600 hospitals in the US, commencing 15th April 2023.
This device aims to improve the safety and ease of surgical retraction for both patients and medical staff.
Angela Spang, founder and owner of JUNE Medical said: “We are delighted to partner with this prominent US hospital group to provide surgeons across the US with the Galaxy II. This award-winning self-retaining surgical retractor has been meticulously designed to overcome the challenges of traditional cumbersome devices, improving the safety of surgery for all, and we are pleased with how well it has already been received by the organisation’s hospitals and advisory board members. This is a true reflection on the quality of our products and manufacturing procedures, as well as our ability to produce medical equipment that makes a real difference to patient care.”
JUNE Medical’s Galaxy II self-retaining retractor was first developed to improve comfort and visualisation for the operating room (OR) team during gynaecological and urological surgery, but it has since been rapidly adopted by all surgical disciplines. The lightweight instrument’s cam lock system is self-retaining and allows single-handed adjustments without screws, removing the reliance on OR assistants to hold surgical sites open, and freeing up personnel for more pressing tasks. The retractor holds securely to the patient with low-profile hooks, giving surgeons control over the degree of tension and avoiding unnecessary trauma or tearing to the skin for better patient care. It is available in multiple frames with various hooks – from sharp to semi-blunt and blunt – and flexible options to suit any patient and any procedure.
Richard Hyde, His Majesty’s consul general in Texas, Department for International Trade, said: “It is easy to support British innovations when they are this popular with customers in North America. The Galaxy II device is not just better for surgeons, it is also better for the environment and for American patients, with cost savings and a safer design. I, along with the UK Department for Business and Trade team, am delighted to see the swift uptake in the US market and congratulate this enterprising hospital group on including Galaxy II in its contract for member buyers.”
Roger Dmochowski, urologic surgeon, added: “Medical innovation is important in all aspects of surgery from patient selection to postoperative care, and, in my experience, it is often the simplest of inventions that make the most difference. The Galaxy II is the epitome of a product that uses ingenuity to modernise surgery and improve patient safety, by swapping cumbersome screws with cam locks. This new partnership will help surgeons across the US to strive for excellence in the operating room and bring surgical equality, as every patient deserves access to great healthcare.”
